The purpose of the research is to determine the effect of the drug "Immunopharm" on blood parameters in highly productive cows before and after treatment of serous mastitis. In order to organize the research, two groups of cows, 10 heads each, with a diagnosis of serous mastitis (experimental and control) were formed in compliance with the sign of similarity. The diagnosis of cervical mastitis was established visually, by palpation of the affected quarter of the mammary gland, trial suturing, attention was paid to the shape of the udder, the symmetry of the quarters, the size of the nipples, the condition of the nipple canal, soreness, local temperature and the condition of the supramuscular lymph nodes. For the treatment of serous mastitis, the drug "Immunopharm" was used in the experimental group at a dose of 10.0 ml, intravenously, with an interval of 12 hours until recovery. The animals of the control group were treated with the drug "Mastisan" in accordance with the instructions at a dose of 5.0 ml with an interval of 24 hours, intracystally. It was found that when used for the treatment of serous mastitis in highly productive cows, the drug "Immunopharm" in a dose of 10.0 ml, intracisternally, with an interval of 12 hours, provides an increase in the morphofunctional state of animals by increasing the content of hemoglobin by 5.96, erythrocytes by 34.37%, platelets by 42.07%, basophils by 0.40%., eosinophils – by 0.80%, segmented neutrophils – by 16.07%, monocytes – by 1.60%, with a decrease in the content of leukocytes – by 17.17%, young – by 1.20% and rod–shaped neutrophils - by 2.07%, lymphocytes – by 7.69%, which indicates the effectiveness of the drug "Immunopharm" in the treatment of serous mastitis compared with the drug "Mastisan" by increasing the immunological status, changing energy processes.
Tenyakov et al. (Sun,) studied this question.